EXPERIMENTAL AND CLINICAL TRANSPLANTATION, cilt.15, ss.21-24, 2017 (SCI-Expanded)
Objectives: Transarterial chemoembolization is a potential risk factor for hepatic artery damage, which may lead to severe consequences. We aimed to investigate this controversial issue in our population of liver transplant patients with hepatocellular carcinoma.